TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 3 | 6 | -5 | -11 | -8 | 18 | 17 | 3 |
| P | %wins | 67 | 33 | 33 | 33 | 67 | 67 | 50 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/28/08 14:46 | 11/25/08 | HSKA | Heska Corp | DE | Health | BioPrd | Biological Products, (No Diag | Flanders John R | CO | O | VP,GC | P | 3 | 0.2300 | 0 | 15 | 86 | 33 | D | -83 | -86 | -80 | -72 | -42 | -36 | -3 | 0 | 11 | -7 | -18 | -29 | 39 | 54 |
11/14/08 17:17 | 11/12/08 | HSKA | Heska Corp | DE | Health | BioPrd | Biological Products, (No Diag | Flanders John R | CO | O | VP,GC | P | 2 | 0.2100 | 0 | 10 | 133 | 18 | D | -84 | -87 | -82 | -72 | -50 | -40 | -39 | -18 | -6 | -15 | -22 | -15 | 15 | 41 |
8/1/07 16:05 | 7/30/07 | HSKA | Heska Corp | DE | Health | BioPrd | Biological Products, (No Diag | Flanders John R | CO | O | VP,GC | P | 5 | 2.09 | 0 | 3 | 100 | 5 | D | 129 | 42 | 16 | -12 | -20 | -35 | -28 | -15 | 14 | 8 | 8 | 21 | -1 | -45 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |